Disclosed herein is a method comprising: causing emission of characteristic X-rays of a first element attached to a first biological analyte; causing emission of characteristic X-rays of a second element attached to a second biological analyte; detecting a characteristic of the first biological analyte based on the characteristic X-rays of the first element and a characteristic of the second biological analyte based on the characteristic X-rays of the second element; wherein the first element and the second element are different; wherein the first biological analyte and the second biological analyte are in the same solution.

An X-ray fluoroscopic imaging apparatus executes an operation of rotating a C-arm continuously using a sequence mode function. The apparatus including a C-arm 9 that supports an X-ray tube 5 and an X-ray detector 7 facing each other, a memory storage element 37 stores a plurality of positions information relative to the C-arm 9 corresponding to an order information related to rotation of C-arm 9 to such a position as a sequence information, a touch panel 43 displays the position information included in the sequence information in parallel along the order of rotation of the C-arm 9, and a display control element 55 controls the touch panel 43 to display the next target rotation information, at which the C-arm 9 irradiates the X-ray, among the position information included is a sequence information SQ1 in a predetermined fixed region R1 of the touch panel 43.

A wedge osteotomy method inserts a first wire into a first bone of the foot, distal from tissue to be removed. A second wire is inserted into a second bone, so the tissue to be removed is distal from the second wire. A cut guide is pivoted about the first wire, until a first axis of the cut guide is parallel with a longitudinal axis of the first metatarsal. The cut guide has a slot perpendicular to the first axis for guiding a cutter to cut bone, while the first axis is aligned with the longitudinal axis of the first metatarsal. The cut guide is then pivoted about the second wire, until the first axis is aligned with the longitudinal axis of the talus, and bone is cut through the slot, to form a second planar cut into or through bone material.

X-ray and fluoroscopic image capture and, in particular, to a versatile X-ray emitter operative to capture images of a target configured to track and position the X-ray emission relative to an image sensor that generates the X-ray image using the X-ray emission. The system is configured to prompt the user or operator of the X-ray system with various informational data to improve the outcome of the X-ray and decrease the frequency of X-ray emissions required to obtain a desirable X-ray image.

A system of medical devices includes a needle, an endoscope, and an introducer. The needle extends between a needle proximal portion and a needle distal portion having a puncturing tip. The endoscope extends between an endoscope proximal portion and an endoscope distal portion having a camera. The introducer is for guiding the needle and the endoscope towards a target location. The introducer extends between an introducer proximal portion and an introducer distal portion and has a first lumen extending therethrough from the introducer proximal portion to the introducer distal portion and a second lumen extending therethrough from the introducer proximal portion to the introducer distal portion. The needle is advanceable through the first lumen to position the puncturing tip proud of the introducer distal portion and the endoscope is advanceable through the second lumen to position the camera proximate the introducer distal portion and outside of the lumen.

A fluoroscopy system includes a fluoroscopy device, an indicating assembly and a center control device. The fluoroscopy device includes a contoured support arm, an X-ray emitting unit, an X-ray sensor and a display unit. The contoured support arm has a first end part and a second end part opposite to the first end part. The X-ray emitting unit is located on the first end part and is configured to emit an X-ray. The X-ray sensor is located on the second end part to sense the X-ray. The display unit is electrically connected to the X-ray sensor. The indicating assembly is located near the contoured support arm and includes a plurality of light emitting units. Each of the plurality of light emitting units is rotatable and configured to emit a light plane. The center control device is electrically connected to the fluoroscopy device and the indicating assembly.

A phosphor excitable by X-ray and blue-light emits light in the near-infrared (NIR-II, 1000-1700 nanometers) forms nanoparticles less than 200 nanometers diameter. The nanoparticles are tagged by coating with silica, then conjugating with polyethylene glycol (PEG) and tissue-selective compounds such as antibodies, nucleic acid chains, and other ligands. In embodiments, we administer the tagged nanoparticles to a subject, then localize the nanoparticles, and thus antigen-bearing tissues, by irradiating the subject with X-ray or other radiation beams while imaging near infrared light emitted from the subject. The nanoparticles are made by mixing 1-50 micron calcium oxide and germanium oxide powders with dilute nitric acid, adding chromium (III) nitrate at a ratio to germanium between 0.001 and 0.1, adding tartaric acid solution with molar ratio to metal ions between 1-10, and adjusting pH to 0.1-4 with nitric acid, then later heating to form a sol, oven drying, and calcinating the sol.

The invention comprises a method and apparatus for imaging a tumor with X-rays while, simultaneously or alternatingly, treating or imaging the tumor with positively charged particles. An X-ray imaging system, such as one or two sets of a cone beam X-ray source coupled to an X-ray detector, is rotatable about a first axis and a patient. The X-ray imaging system is positioned off axis a path of charged particles delivered through an exit port of a nozzle system from a synchrotron and does not block a path of the positively charged particles from the exit nozzle to the patient or an imaging path from the patient to a scintillation detector. Fiducial indicators are used to confirm an unobstructed path of the positively charged particles in a treatment room comprising many movable elements, such as the X-ray imaging system and a patient positioning system/couch.

The present disclosure provides systems and methods for predicting a disease state of a subject using ultrasound imaging and ancillary information to the ultrasound imaging. At least two quantitative measurements of a subject, including at least one measurement taken using ultrasound imaging, as part of quantified information can be identified. One of the quantitative measurements can be compared to a first predetermined standard, included as part of ancillary information to the quantified information, in order to identify a first initial value. Further, another of the quantitative measurements can be compared to a second predetermined standard, included as part of the ancillary information, in order to identify a second initial value. Subsequently, the quantitative information can be correlated with the ancillary information using the first initial value and the second initial value to determine a final value that is predictive of a disease state of the subject.

An improved local anesthetic solution with diminished bitter taste includes an anesthetic agent, an anesthetic solution vehicle, and a bitterness suppressant. The bitterness suppressant includes one or more compounds selected from the group consisting of: a sugar selected from the group consisting of monosaccharide sugars, disaccharide sugars, polysaccharide sugars, and combinations of the any of the foregoing; sweet-tasting compounds; acids; amino acids; salts; miscellaneous suppressant substances; and combinations of any of the foregoing. The improved local anesthetic solution optionally includes one or more additional agents selected from the group consisting of: buffering agents; vasoconstrictors; preservative compounds; stabilizers; contrast media agents; and combinations of any of the foregoing.